Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 22,928,078
  • Shares Outstanding, K 72,422
  • Annual Sales, $ 2,950 M
  • Annual Income, $ 593,400 K
  • EBIT $ 571 M
  • EBITDA $ 709 M
  • 60-Month Beta 1.00
  • Price/Sales 7.88
  • Price/Cash Flow 31.52
  • Price/Book 8.44

Options Overview Details

View History
  • Implied Volatility 27.02% ( -2.72%)
  • Historical Volatility 58.14%
  • IV Percentile 27%
  • IV Rank 15.98%
  • IV High 54.39% on 10/23/24
  • IV Low 21.82% on 11/27/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 367
  • Volume Avg (30-Day) 377
  • Put/Call OI Ratio 2.15
  • Today's Open Interest 9,307
  • Open Int (30-Day) 7,884

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.79
  • Number of Estimates 5
  • High Estimate 1.91
  • Low Estimate 1.72
  • Prior Year 1.83
  • Growth Rate Est. (year over year) -2.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
283.36 +11.73%
on 10/23/24
352.33 -10.14%
on 10/24/24
+30.19 (+10.54%)
since 10/22/24
3-Month
281.00 +12.67%
on 10/09/24
352.33 -10.14%
on 10/24/24
+16.07 (+5.35%)
since 08/22/24
52-Week
265.00 +19.47%
on 07/25/24
413.70 -23.47%
on 02/07/24
-34.58 (-9.85%)
since 11/22/23

Most Recent Stories

More News
Stocks Settle Mostly Higher on Positive Corporate Earnings

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up by +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down by -0.33%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up by +0.83%. Stocks...

TER : 108.21 (+2.55%)
CARR : 77.00 (+1.30%)
TXN : 198.00 (-0.10%)
$IUXX : 20,776.23 (+0.17%)
CBRE : 135.43 (+2.87%)
RJF : 165.18 (+0.85%)
ZNZ24 : 109-205s (+0.13%)
TXT : 85.38 (+1.69%)
TSLA : 352.56 (+3.80%)
GFS : 42.80 (+1.90%)
IBM : 222.97 (+0.26%)
KDP : 32.66 (+1.30%)
Stocks Rise on Strong Earnings Results and Soft-Landing Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.63%. Stocks today are mostly...

TER : 108.21 (+2.55%)
CARR : 77.00 (+1.30%)
$SPX : 5,969.34 (+0.35%)
HON : 229.11 (+1.34%)
MOH : 290.79 (-1.78%)
$IUXX : 20,776.23 (+0.17%)
CBRE : 135.43 (+2.87%)
RJF : 165.18 (+0.85%)
QQQ : 505.79 (+0.16%)
ZNZ24 : 109-205s (+0.13%)
TMUS : 238.28 (+0.72%)
TXT : 85.38 (+1.69%)
Stocks Mostly Higher on Strong Earnings Results from Tesla and UPS

The S&P 500 Index ($SPX ) (SPY ) today is up by +0.23%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down by -0.28%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.65%. Stocks today are mostly...

TER : 108.21 (+2.55%)
CARR : 77.00 (+1.30%)
$SPX : 5,969.34 (+0.35%)
HON : 229.11 (+1.34%)
MOH : 290.79 (-1.78%)
$IUXX : 20,776.23 (+0.17%)
CBRE : 135.43 (+2.87%)
RJF : 165.18 (+0.85%)
QQQ : 505.79 (+0.16%)
ZNZ24 : 109-205s (+0.13%)
TMUS : 238.28 (+0.72%)
TXT : 85.38 (+1.69%)
West Pharmaceutical: Q3 Earnings Snapshot

West Pharmaceutical: Q3 Earnings Snapshot

WST : 316.59 (-1.34%)
What to Expect From West Pharmaceutical's Next Quarterly Earnings Report

West Pharmaceutical is scheduled to report its third-quarter results later this month, and analysts expect a double-digit earnings decline.

XLV : 144.16 (+0.09%)
$SPX : 5,969.34 (+0.35%)
WST : 316.59 (-1.34%)
West Pharmaceutical Stock: Is WST Underperforming the Healthcare Sector?

Despite West Pharmaceutical underperforming the healthcare sector, Wall Street analysts remain highly optimistic about the stock’s prospects.

XLV : 144.16 (+0.09%)
TMO : 513.26 (-0.55%)
WST : 316.59 (-1.34%)
Are Wall Street Analysts Predicting West Pharmaceutical Services Stock Will Climb or Sink?

West Pharmaceutical Services has underperformed the broader market over the past year, but Wall Street analysts remain optimistic about the stock’s prospects.

WST : 316.59 (-1.34%)
$SPX : 5,969.34 (+0.35%)
MDEV : 21.10 (+0.42%)
West Pharmaceutical: Q2 Earnings Snapshot

West Pharmaceutical: Q2 Earnings Snapshot

WST : 316.59 (-1.34%)
What to Expect From West Pharmaceutical Services' Q2 2024 Earnings Report

West Pharmaceutical is expected to release its second-quarter earnings later this month, and analysts project a double-digit profit dip.

WST : 316.59 (-1.34%)
$SPX : 5,969.34 (+0.35%)
XLV : 144.16 (+0.09%)
3 Near-oversold Dividend Aristocrats To Buy Before They Pop

These three Dividend Aristocrats trade near oversold levels and offer reliable income and potential capital appreciation.

NUE : 151.92 (+1.29%)
ABT : 117.76 (+0.43%)
WST : 316.59 (-1.34%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical...

See More

Key Turning Points

3rd Resistance Point 331.38
2nd Resistance Point 328.19
1st Resistance Point 322.39
Last Price 316.59
1st Support Level 313.40
2nd Support Level 310.21
3rd Support Level 304.41

See More

52-Week High 413.70
Fibonacci 61.8% 356.90
Fibonacci 50% 339.35
Fibonacci 38.2% 321.80
Last Price 316.59
52-Week Low 265.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar